Goodbye to LD50?
Drug companies should stop using a classic toxicity test, lethal dose 50 (LD50), to inform clinical trials, according to authors in an upcoming journal of Regulatory Toxicology and Pharmacology linkurl:report.;http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WPT-4R8WK2M-1-1&_cdi=6999&_user=10&_orig=browse&_coverDate=12%2F05%2F2007&_sk=999999999&view=c&wchp=dGLbVlz-zSkWW&md5=db03ae20cfcfde5f302c238ad0633bbc&ie=/sdarticle.pdf Mouse data of a drug's LD50, the dose of a drug that kills 50%

The Scientist ARCHIVES
Become a Member of
Meet the Author
Edyta Zielinska
This person does not yet have a bio.View full profile